Related Experiment Video
Updated: Dec 25, 2025

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Chronic Thrombocytopenia as the Initial Manifestation of STIM1-Related Disorders
Anjali Sura1, Joseph Jacher2, Erin Neil3
1Divisions of Pediatric Rheumatology.
Insights
Genetic testing revealed STIM1 variants causing Stormorken syndrome in a teen with chronic thrombocytopenia, constitutional symptoms, and myopathy. This case highlights overlapping phenotypes and the need for multidisciplinary care.
Area of Science:
- Genetics
- Pediatrics
- Immunology
Background:
- Pediatric thrombocytopenia presents a broad differential diagnosis.
- Genetic testing is increasingly utilized to determine the etiology of thrombocytopenia.
- Chronic thrombocytopenia can be associated with complex systemic symptoms.
Purpose of the Study:
- To report a novel case of pediatric thrombocytopenia with overlapping Stormorken syndrome phenotypes.
- To emphasize the importance of genetic testing in diagnosing complex pediatric hematologic disorders.
- To highlight the diagnostic utility of muscle enzyme evaluation in patients with thrombocytopenia and myopathic symptoms.
Main Methods:
- Case presentation of a 16-year-old male with chronic thrombocytopenia.
- Comprehensive laboratory evaluation including inflammatory markers and muscle enzymes.
- Diagnostic imaging (lymphadenopathy, asplenia) and muscle biopsy.
- Ophthalmological assessment.
- Genetic testing for STIM1 pathogenic variants.
Main Results:
- The patient presented with chronic thrombocytopenia, constitutional symptoms, hand edema, inflammation, elevated muscle enzymes, lymphadenopathy, asplenia, and myopathy.
- Genetic analysis identified a pathogenic STIM1 variant, consistent with autosomal dominant Stormorken syndrome.
- The observed phenotype demonstrated an overlap between previously described gain-of-function and loss-of-function STIM1 variants.
Conclusions:
- This case expands the phenotypic spectrum associated with STIM1 variants, blurring distinctions between related syndromes.
- Multidisciplinary care and genetic testing are crucial for managing chronic, unexplained pediatric thrombocytopenia.
- Elevated muscle enzymes should be considered in the workup of pediatric patients with thrombocytopenia and associated neuromuscular symptoms.
Abstract:
Pediatric thrombocytopenia has a wide differential diagnosis, and recently, genetic testing to identify its etiology has become more common. We present a case of a 16-year-old boy with a history of chronic moderate thrombocytopenia, who later developed constitutional symptoms and bilateral hand edema with cold exposure. Laboratory evaluation revealed evidence both of inflammation and elevated muscle enzymes. These abnormalities persisted over months. His thrombocytopenia was determined to be immune mediated. Imaging revealed lymphadenopathy and asplenia, and a muscle biopsy was consistent with tubular aggregate myopathy. Ophthalmology evaluation noted photosensitivity, pupillary miosis, and iris hypoplasia. Genetic testing demonstrated a pathogenic variant in STIM1 consistent with autosomal dominant Stormorken syndrome. Our case is novel because of the overlap of phenotypes ascribed to both gain-of-function and loss-of-function pathogenic variants in STIM1, thereby blurring the distinctions between these previously described syndromes. Pediatricians should consider checking muscle enzymes when patients present with thrombocytopenia and arthralgia, myalgia, and/or muscle weakness. Our case highlights the importance of both multidisciplinary care and genetic testing in cases of chronic unexplained thrombocytopenia. By understanding the underlying genetic mechanism to a patient's thrombocytopenia, providers are better equipped to make more precise medical management recommendations.
More Related Videos
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Regulation of Hematopoietic Stem Cells
Intracellular Signaling Affects Focal Adhesions
Some...

